Table 2.
Characteristics | N. of Patients (n = 20) |
---|---|
Number of liver metastases | |
1 >1 |
13 7 |
Systemic therapy pre-liver surgery |
|
0 ≥1 |
6 14 |
Best response of therapy before surgery PR SD PD |
14 * 10 3 1 |
Immunophenotype | |
Luminal HER2+ TNBC |
13 3 4 |
N.: number. *: number of patients who received treatments before surgery. CR: complete response, PR: partial response, SD: stable disease.